Inhaled Mometasone to Reduce Painful Episodes in Patients With Sickle Cell Disease
Clinical trial NCT02061202 · COMPLETED
Trial details
- NCT number
- NCT02061202
- Sponsor
- Jeffrey Glassberg
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2017-11-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.